Ownership history in RENAISSANCE TECHNOLOGIES LLC · 36 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,545,260 | +683,060 | +36.7% | 0.01% | $8.1M | $3.19 |
| 2025 Q2 | ADDED | 1,862,200 | +706,200 | +61.1% | 0.01% | $4.2M | $2.27 |
| 2025 Q1 | REDUCED | 1,156,000 | -190,800 | -14.2% | 0.00% | $735K | $0.64 |
| 2024 Q4 | ADDED | 1,346,800 | +331,800 | +32.7% | 0.00% | $1.4M | $1.03 |
| 2024 Q3 | REDUCED | 1,015,000 | -168,022 | -14.2% | 0.00% | $1.2M | $1.18 |
| 2024 Q2 | REDUCED | 1,183,022 | -49,778 | -4.0% | 0.00% | $1.4M | $1.22 |
| 2024 Q1 | REDUCED | 1,232,800 | -92,900 | -7.0% | 0.00% | $2.7M | $2.18 |
| 2023 Q4 | ADDED | 1,325,700 | +395,600 | +42.5% | 0.00% | $2.1M | $1.55 |
| 2023 Q3 | REDUCED | 930,100 | -192,300 | -17.1% | 0.00% | $1.2M | $1.29 |
| 2023 Q2 | ADDED | 1,122,400 | +272,100 | +32.0% | 0.00% | $1.9M | $1.72 |
As of 2025 Q4 — sorted by position size